Taurine is a weak scavenger of peroxynitrite and does not attenuate sodium nitroprusside toxicity to cells in culture

Amino Acids

Volumn 20, Issue 4, 2001, Pages 419-433

  Mehta, T R ^a   Dawson, Jr ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Amino acids; Hypotaurine; Neurotoxicity; Nitric oxide; Peroxynitrite; Sodium nitroprusside; Taurine

Indexed keywords

BETA ALANINE; HOMOTAURINE; HYPOTAURINE; ISETHIONIC ACID; LINSIDOMINE; NITROPRUSSIDE SODIUM; PEROXYNITRITE; RHODAMINE; SCAVENGER; TAURINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN; CELL VIABILITY; CONCENTRATION RESPONSE; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; CELL DEATH; CELL DIVISION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; FREE RADICALS; MOLSIDOMINE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PC12 CELLS; PEROXYNITROUS ACID; RATS; RHODAMINES; TAURINE; TIME FACTORS;

ANIMALIA;

EID: 0034995284     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007260170038     Document Type: Article

References (50)

1. Formation of peroxynitrite during thiol-mediated reduction of sodium nitroprusside
2. The antioxidant action of taurine, hypotaurine and their metabolic precusors
3. Nitric oxide, superoxide, and peroxynitrite: The good the bad, and the ugly
4. Carnosine and taurine protect cerebellar granular cells from free radical damage
5. Defenses against peroxynitrite
6. Taurine modulation of hypochlorous acid - Induced lung epithelial cell injury in vitro
7. Effect of taurine on human fetal neuron cells: Proliferation and differentiation
8. Neurotoxic and neuroprotective roles of nitric oxide in cerebral ischemia
9. Taurine inhibition of metal-stimulated catecholamine oxidation
10. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostatis and energy metabolism
11. Peroxynitrite-induced cytotoxicity in PC12 cells: Evidence for an apoptotic mechanism differently modulated by neurotrophic factors
12. Nonsynaptic glycine receptor activation during early neocortical development
13. Effect of nitric oxide on mitogenesis and proliferation of cerebellar glial cells
14. 2 -induced alterations
15. Antioxidant role and subcellular localization of hypotaurine and taurine in human neutrophils
16. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor
17. A novel synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro
18. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites
19. Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: Possible role in osmoregulation
20. Taurine in the central nervous system and the mammalian actions of taurine
21. Physiological action of taurine
22. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation-nitrotyrosine in serum and synovial fluid from rheumatoid patients
23. Antioxidant activity of retinol, glutathione, and taurine in bovine photoreceptor cell membranes
24. Modelling of cortical cataractogenesis 22: Is in vitro reduction of damage in model diabetic rat cataract by taurine due to its antioxidant activity
25. Peroxynitrite-mediated oxidation of dihydrorhodamine 123
26. Antimutagenic effects of taurine in a bacterial assay system
27. The critical role of HEPES in SIN-1 cytotoxicity, peroxynitrite versus hydrogen peroxide
28. Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators
29. Neutrophil chloramines: Missing links between innate and acquired immunity
30. Reduction of reperfusion injury with preoperative rapid infusion of taurine during myocardial revascularization
31. Quantitative evaluation of the effectiveness of taurine in protecting the ocular surface against oxidant
32. Metal complexes of taurine. The first reported solution equilibrium studies for complex formation by taurine at physiological pH; the copper(II)-glycylglycinate-taurine and copper(II)-glycylaspartate-taurine systems
33. Taurine chloramine inhibits production of nitric oxide and TNF-α in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events
34. Preactivation exposure of RAW 246.7 cells to taurine chloramine attenuates subsequent production of nitric oxide and expression of iNOS mRNA
35. Taurine and hypotaurine inhibit light-induced lipid peroxidation and protect rod outer segment structure
36. Taurine protects the heart from neutrophil induced reperfusion injury
37. Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury
38. Immunonutrition: The role of taurine
39. Taurine blunts LPS-induced increases in intracellular calcium and TNF-α production by Kupffer cells
40. Efficacy of taurine based compounds as hydroxyl radical scavengers in silica induced peroxidation
41. Taurine, hypotaurine, epinephrine, and albumin inhibit lipid peroxidation in rabbit spermatozoa and protect against loss of motility
42. Biphasic effect of taurine on excitatory amino acid-induced neurotoxicity
43. Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils
44. The in vivo and in vitro protective effects of taurine
45. A tetrazolium-based colorimetric MIT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia
46. Eosinophil apoptosis is mediated by stimulators of cellular oxidative metabolism and inhibited by antioxidants: Involvement of a thiol-sensitive redox regulation in eosinophil cell death
47. Chlorination of taurine of by human neutrophils
48. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis
49. Inhibition of rat vascular smooth muscle cell proliferation by taurine and taurine analogues
50. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF